Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 2
2021 2
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological Targeting of IRE1 in Cancer.
Raymundo DP, Doultsinos D, Guillory X, Carlesso A, Eriksson LA, Chevet E. Raymundo DP, et al. Among authors: guillory x. Trends Cancer. 2020 Dec;6(12):1018-1030. doi: 10.1016/j.trecan.2020.07.006. Epub 2020 Aug 26. Trends Cancer. 2020. PMID: 32861679 Free article. Review.
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment.
Pelizzari-Raymundo D, Doultsinos D, Pineau R, Sauzay C, Koutsandreas T, Langlais T, Carlesso A, Gkotsi E, Negroni L, Avril T, Chatziioannou A, Chevet E, Eriksson LA, Guillory X. Pelizzari-Raymundo D, et al. Among authors: guillory x. iScience. 2023 Apr 24;26(5):106687. doi: 10.1016/j.isci.2023.106687. eCollection 2023 May 19. iScience. 2023. PMID: 37216120 Free PMC article.
Structure-Based Drug Discovery of IRE1 Modulators.
Pelizzari Raymundo D, Eriksson LA, Chevet E, Guillory X. Pelizzari Raymundo D, et al. Among authors: guillory x. Methods Mol Biol. 2022;2378:293-315. doi: 10.1007/978-1-0716-1732-8_19. Methods Mol Biol. 2022. PMID: 34985708 Free article.
Structural and molecular bases to IRE1 activity modulation.
Langlais T, Pelizzari-Raymundo D, Mahdizadeh SJ, Gouault N, Carreaux F, Chevet E, Eriksson LA, Guillory X. Langlais T, et al. Among authors: guillory x. Biochem J. 2021 Aug 13;478(15):2953-2975. doi: 10.1042/BCJ20200919. Biochem J. 2021. PMID: 34375386 Free article. Review.
Fragment-based Differential Targeting of PPI Stabilizer Interfaces.
Guillory X, Wolter M, Leysen S, Neves JF, Kuusk A, Genet S, Somsen B, Morrow JK, Rivers E, van Beek L, Patel J, Goodnow R, Schoenherr H, Fuller N, Cao Q, Doveston RG, Brunsveld L, Arkin MR, Castaldi P, Boyd H, Landrieu I, Chen H, Ottmann C. Guillory X, et al. J Med Chem. 2020 Jul 9;63(13):6694-6707. doi: 10.1021/acs.jmedchem.9b01942. Epub 2020 Jun 23. J Med Chem. 2020. PMID: 32501690 Free PMC article.
Supramolecular Enhancement of a Natural 14-3-3 Protein Ligand.
Guillory X, Hadrović I, de Vink PJ, Sowislok A, Brunsveld L, Schrader T, Ottmann C. Guillory X, et al. J Am Chem Soc. 2021 Sep 1;143(34):13495-13500. doi: 10.1021/jacs.1c07095. Epub 2021 Aug 24. J Am Chem Soc. 2021. PMID: 34427424
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient.
Leclerc D, Goujon L, Jaillard S, Nouyou B, Cluzeau L, Damaj L, Dubourg C, Etcheverry A, Levade T, Froissart R, Dréano S, Guillory X, Eriksson LA, Launay E, Mouriaux F, Belaud-Rotureau MA, Odent S, Gilot D. Leclerc D, et al. Among authors: guillory x. CRISPR J. 2023 Feb;6(1):17-31. doi: 10.1089/crispr.2022.0045. Epub 2023 Jan 11. CRISPR J. 2023. PMID: 36629845 Free PMC article.
The Molecular Tweezer CLR01 Stabilizes a Disordered Protein-Protein Interface.
Bier D, Mittal S, Bravo-Rodriguez K, Sowislok A, Guillory X, Briels J, Heid C, Bartel M, Wettig B, Brunsveld L, Sanchez-Garcia E, Schrader T, Ottmann C. Bier D, et al. Among authors: guillory x. J Am Chem Soc. 2017 Nov 15;139(45):16256-16263. doi: 10.1021/jacs.7b07939. Epub 2017 Nov 2. J Am Chem Soc. 2017. PMID: 29039919 Free PMC article.
13 results